4th PREDiCT Tumor Models San Francisco

January 22 - January 24, 2020
San Francisco, CA

MI Bioresearch is proud to be a Spotlight Partner of 4th PREDiCT Tumor Models San Francisco 2020. Stop by our booth with any questions or contact us to set up a time to meet while in San Francisco. Let’s talk about your upcoming preclinical oncology CRO needs. Find out what MI Bioresearch has to offer in the way of tumor models, in vivo imaging, in vitro services, flow cytometry, and focal radiation.

In attendance from MI Bioresearch (tentative):

  • Dr. Gregor Adams | Director, Scientific Development
  • Steve Reed | Sr. Director, Business Development

Speaking Engagement

Time & Date TBD
“Identifying Predictive and Prognostic Biomarkers through Preclinical Modeling of Syngeneic Tumors”

  • Evading the host immune response is a recognized hallmark of cancer
  • Comprehensive analysis of the immune cells in immunocompetent tumor models is essential for the development of novel therapies and understanding their mechanism of action in vivo
  • We have accumulated data from different model systems to identify key differences between tumors that respond (hot) or do not respond (cold) to immunomodulatory agents

Image of Gregor Adams, PhD - Director, Scientific Development

Presented by:
Dr. Gregor Adams
Director, Scientific Development

 

 

Website-logo-1

View the Conference Website